Go to deals
Consumer & Retail

Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange

Pilulka Lékárny a.s. has completed an IPO on START Market of the Prague Stock Exchange consisting of capital increase and disposal of secondary shares.

Founded in 2013, Pilulka is one of the most significant players consolidating the online and offline pharmacy markets in Central Europe. Pilulka is the number one pharmacy e-shop in the home delivery segment in the Czech Republic and Slovakia, and among the top three retail pharmacy chains in the Czech Republic, with 152 branded pharmacies. The company entered the Romanian online pharmacy market in 2018 and plans to expand to Hungary in 2021. Pilulka is a data-driven market disruptor leveraging its tailor-made and easily scalable IT solutions. Furthermore, the company is backed by a strong management team led by Czech e-commerce tycoons Petr and Martin Kasa, who founded the company.

Oaklins’ team in the Czech Republic acted as IPO manager in this transaction. The team succeeded in attracting orders from high-net-worth individuals and experienced investors, and also from a broad range of retail and institutional investors.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Miloš  Čebík

Miloš Čebík

Director

Prague, Czech Republic
Oaklins WOOD & Co.
 Robin  Ibl

Robin Ibl

Associate

Prague, Czech Republic
Oaklins WOOD & Co.

Related deals

Alice Queen (ASX:AQX) has raised funds via an institutional placement
Other Industries

Alice Queen (ASX:AQX) has raised funds via an institutional placement

Alice Queen Limited (ASX:AQX) has completed a fundraising. The funds will be used to complete the Horn Island Scoping Study, accelerate exploration activities at Horn Island and support working capital. The placement was significantly oversubscribed and strongly supported by a major shareholder, as well as several existing shareholders and new institutional and sophisticated investors.

Learn more
Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.
TMT

Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.

Bigtincan Holdings Limited (ASX:BTH) has raised US$98.6 via a placement and underwritten accelerated non-renounceable entitlement offer.

Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Healthcare

Poolbeg Pharma has completed an Initial Public Offering on AIM

Poolbeg Pharma Plc has raised funds to develop the company.

Learn more